Joseph Stringer
Stock Analyst at Needham
(3.31)
# 940
Out of 4,670 analysts
274
Total ratings
37.85%
Success rate
5.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXRX Lexicon Pharmaceuticals | Reiterates: Hold | n/a | $0.86 | - | 8 | Nov 22, 2024 | |
| VIR Vir Biotechnology | Reiterates: Buy | $19 | $7.12 | +166.85% | 15 | Nov 20, 2024 | |
| ANNX Annexon | Reiterates: Buy | $16 | $5.14 | +211.28% | 17 | Nov 15, 2024 | |
| RNA Avidity Biosciences | Reiterates: Buy | $60 | $43.25 | +38.73% | 15 | Nov 13, 2024 | |
| MRNA Moderna | Reiterates: Hold | n/a | $41.11 | - | 8 | Nov 8, 2024 | |
| GILD Gilead Sciences | Reiterates: Hold | n/a | $90.19 | - | 3 | Nov 7, 2024 | |
| IONS Ionis Pharmaceuticals | Reiterates: Buy | $60 | $34.01 | +76.42% | 16 | Nov 7, 2024 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $55 → $64 | $59.94 | +6.77% | 18 | Nov 6, 2024 | |
| PCVX Vaxcyte | Reiterates: Buy | $140 | $88.54 | +58.12% | 12 | Nov 6, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $85 → $60 | $30.77 | +95.00% | 19 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $11.43 | +92.48% | 18 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $2.81 | +718.51% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $320 | $244.89 | +30.67% | 16 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $9.34 | +178.37% | 45 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $20.40 | +22.55% | 8 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $12.98 | +192.76% | 14 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $450.97 | - | 2 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.31 | - | 16 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $16.37 | +126.02% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $9.47 | +90.07% | 2 | Aug 24, 2021 |
Lexicon Pharmaceuticals
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.86
Upside: -
Vir Biotechnology
Nov 20, 2024
Reiterates: Buy
Price Target: $19
Current: $7.12
Upside: +166.85%
Annexon
Nov 15, 2024
Reiterates: Buy
Price Target: $16
Current: $5.14
Upside: +211.28%
Avidity Biosciences
Nov 13, 2024
Reiterates: Buy
Price Target: $60
Current: $43.25
Upside: +38.73%
Moderna
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $41.11
Upside: -
Gilead Sciences
Nov 7, 2024
Reiterates: Hold
Price Target: n/a
Current: $90.19
Upside: -
Ionis Pharmaceuticals
Nov 7, 2024
Reiterates: Buy
Price Target: $60
Current: $34.01
Upside: +76.42%
Rhythm Pharmaceuticals
Nov 6, 2024
Maintains: Buy
Price Target: $55 → $64
Current: $59.94
Upside: +6.77%
Vaxcyte
Nov 6, 2024
Reiterates: Buy
Price Target: $140
Current: $88.54
Upside: +58.12%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Buy
Price Target: $85 → $60
Current: $30.77
Upside: +95.00%
Nov 6, 2024
Reiterates: Buy
Price Target: $22
Current: $11.43
Upside: +92.48%
Nov 6, 2024
Reiterates: Buy
Price Target: $23
Current: $2.81
Upside: +718.51%
Nov 1, 2024
Reiterates: Buy
Price Target: $320
Current: $244.89
Upside: +30.67%
Sep 13, 2024
Reiterates: Buy
Price Target: $26
Current: $9.34
Upside: +178.37%
Aug 14, 2024
Reiterates: Buy
Price Target: $25
Current: $20.40
Upside: +22.55%
Aug 8, 2024
Reiterates: Buy
Price Target: $38
Current: $12.98
Upside: +192.76%
Jul 26, 2024
Reiterates: Hold
Price Target: n/a
Current: $450.97
Upside: -
Jun 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.31
Upside: -
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $16.37
Upside: +126.02%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $9.47
Upside: +90.07%